These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 25826037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 4. Extensive postoperative ecchymosis in a patient taking dabigatran.
    Wagner CA, Oberoi N, Ahluwalia PK.
    J Minim Invasive Gynecol; 2013; 20(1):127-30. PubMed ID: 23312256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 8. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal sloughing mucosal casts: dabigatran-induced oesophagitis.
    Matsuura H, Suto K, Yasuhara H, Hata H.
    Eur Heart J; 2018 Sep 21; 39(36):3400. PubMed ID: 30169635
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L, Sherman O.
    Ann Pharmacother; 2011 Jul 01; 45(7-8):e40. PubMed ID: 21712509
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
    Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA.
    Am J Emerg Med; 2014 Nov 01; 32(11):1433-4. PubMed ID: 25239691
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.